Cite
MLA Citation
Emily J. Gallagher et al.. “Expert consensus recommendations for managing hyperglycemia and rash in patients with PIK3CA-mutated, hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER2–) advanced breast cancer (ABC) treated with alpelisib (ALP)..” Journal of clinical oncology, vol. 40, no. 28, n.d., p. 422. http://access.bl.uk/ark:/81055/vdc_100169172737.0x000037